Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson’s Disease View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2005

AUTHORS

Heiko Braak , Kelly Del Tredici

ABSTRACT

The pathological process that underlies idiopathic Parkinson’s disease (IPD) progresses relentlessly and requires years to reach its full extent, provided it is not terminated prematurely by death. The severity of the pathology increases gradually during the course of the disorder (1–8). As such, the lesions develop already, to a mild or moderate degree, even in the nervous system of persons whose clinical protocols fail to note the onset or presence of classical IPD-associated motor symptoms (9–17). Thus, the course of the disease process can be subdivided into presymptomatic and symptomatic phases (Fig. 1A). (3, 5) Like the tip of an iceberg, it is only the symptomatic, later phase of the larger degenerative process that presently can be detected clinically.Fig. 1. (A)Presymptomatic and symptomatic phases of idiopathic Parkinson’s disease (IPD). The presymptomatic phase of the disorder is characterized by the appearance of IPD-associated lesions in the brain of asymptomatic persons. Individuals first become symptomatic when the neuropathological threshold is exceeded (approximated by the white vertical line). Increasing density of the shading in areas underneath the diagonal indicates the growing severity of the pathology in vulnerable key regions indicated at the right-hand margin. Arabic numerals mark the stages of the neuropathological process. (B-D) Schematic diagrams showing the gradual ascent of the pathological process underlying IPD (white arrows). (E) Selective vulnerability and resistance of specific neuronal types to IPD. Projection cells that generate long and thin axons are among the nerve cell types most vulnerable to the pathology, whereas projection cells and local circuit neurons with short axon resist the lesions. Heavy axonal myelination offers the following advantages: high speed of conduction, low energy expenditure, greater stability of the parent neuron. Resistant against IPD-related pathology are long-axoned and sturdily myelinated projection neurons. In contrast, vulnerable neuronal types give off unmyelinated or poorly myelinated and thin axons. Reproduced from ref. 6 with permission from Steinkopff Verlag. More... »

PAGES

475-502

Book

TITLE

Dopamine and Glutamate in Psychiatric Disorders

ISBN

978-1-58829-325-1
978-1-59259-852-6

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-59259-852-6_20

DOI

http://dx.doi.org/10.1007/978-1-59259-852-6_20

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053640909


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7839.5", 
          "name": [
            "Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Braak", 
        "givenName": "Heiko", 
        "id": "sg:person.01053255500.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053255500.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany", 
          "id": "http://www.grid.ac/institutes/grid.7839.5", 
          "name": [
            "Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Del Tredici", 
        "givenName": "Kelly", 
        "id": "sg:person.01340323332.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340323332.00"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2005", 
    "datePublishedReg": "2005-01-01", 
    "description": "The pathological process that underlies idiopathic Parkinson\u2019s disease (IPD) progresses relentlessly and requires years to reach its full extent, provided it is not terminated prematurely by death. The severity of the pathology increases gradually during the course of the disorder (1\u20138). As such, the lesions develop already, to a mild or moderate degree, even in the nervous system of persons whose clinical protocols fail to note the onset or presence of classical IPD-associated motor symptoms (9\u201317). Thus, the course of the disease process can be subdivided into presymptomatic and symptomatic phases (Fig. 1A). (3, 5) Like the tip of an iceberg, it is only the symptomatic, later phase of the larger degenerative process that presently can be detected clinically.Fig. 1. (A)Presymptomatic and symptomatic phases of idiopathic Parkinson\u2019s disease (IPD). The presymptomatic phase of the disorder is characterized by the appearance of IPD-associated lesions in the brain of asymptomatic persons. Individuals first become symptomatic when the neuropathological threshold is exceeded (approximated by the white vertical line). Increasing density of the shading in areas underneath the diagonal indicates the growing severity of the pathology in vulnerable key regions indicated at the right-hand margin. Arabic numerals mark the stages of the neuropathological process. (B-D) Schematic diagrams showing the gradual ascent of the pathological process underlying IPD (white arrows). (E) Selective vulnerability and resistance of specific neuronal types to IPD. Projection cells that generate long and thin axons are among the nerve cell types most vulnerable to the pathology, whereas projection cells and local circuit neurons with short axon resist the lesions. Heavy axonal myelination offers the following advantages: high speed of conduction, low energy expenditure, greater stability of the parent neuron. Resistant against IPD-related pathology are long-axoned and sturdily myelinated projection neurons. In contrast, vulnerable neuronal types give off unmyelinated or poorly myelinated and thin axons. Reproduced from ref. 6 with permission from Steinkopff Verlag.", 
    "editor": [
      {
        "familyName": "Schmidt", 
        "givenName": "Werner J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Reith", 
        "givenName": "Maarten E. A.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-59259-852-6_20", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-58829-325-1", 
        "978-1-59259-852-6"
      ], 
      "name": "Dopamine and Glutamate in Psychiatric Disorders", 
      "type": "Book"
    }, 
    "keywords": [
      "idiopathic Parkinson's disease", 
      "Parkinson's disease", 
      "projection cells", 
      "symptomatic phase", 
      "neuronal types", 
      "classical idiopathic Parkinson's disease", 
      "thin axons", 
      "local circuit neurons", 
      "pathological processes", 
      "nerve cell types", 
      "inclusion body pathology", 
      "specific neuronal types", 
      "circuit neurons", 
      "asymptomatic persons", 
      "motor symptoms", 
      "projection neurons", 
      "symptomatic stage", 
      "presymptomatic phase", 
      "selective vulnerability", 
      "parent neurons", 
      "axonal myelination", 
      "disease process", 
      "neuropathological processes", 
      "nervous system", 
      "short axons", 
      "degenerative process", 
      "clinical protocols", 
      "lower energy expenditure", 
      "disease", 
      "pathology", 
      "lesions", 
      "neurons", 
      "axons", 
      "energy expenditure", 
      "late phase", 
      "severity", 
      "moderate degree", 
      "disorders", 
      "gradual ascent", 
      "cell types", 
      "cells", 
      "persons", 
      "symptoms", 
      "course", 
      "myelination", 
      "brain", 
      "death", 
      "onset", 
      "full extent", 
      "key regions", 
      "years", 
      "individuals", 
      "stage", 
      "types", 
      "appearance", 
      "protocol", 
      "contrast", 
      "resistance", 
      "expenditure", 
      "presence", 
      "threshold", 
      "extent", 
      "margin", 
      "vulnerability", 
      "degree", 
      "phase", 
      "area", 
      "greater stability", 
      "region", 
      "Arabic numerals", 
      "conduction", 
      "permission", 
      "process", 
      "tip", 
      "icebergs", 
      "advantages", 
      "system", 
      "ascent", 
      "density", 
      "stability", 
      "speed", 
      "Verlag", 
      "Ref. 6", 
      "numerals", 
      "schematic diagram", 
      "high speed", 
      "diagram", 
      "shading", 
      "larger degenerative process", 
      "appearance of IPD", 
      "neuropathological threshold", 
      "vulnerable key regions", 
      "right-hand margin", 
      "Heavy axonal myelination", 
      "IPD-related pathology", 
      "vulnerable neuronal types", 
      "Steinkopff Verlag", 
      "Intracerebral Inclusion Body Pathology", 
      "Body Pathology"
    ], 
    "name": "Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson\u2019s Disease", 
    "pagination": "475-502", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053640909"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-59259-852-6_20"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-59259-852-6_20", 
      "https://app.dimensions.ai/details/publication/pub.1053640909"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_370.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-59259-852-6_20"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-59259-852-6_20'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-59259-852-6_20'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-59259-852-6_20'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-59259-852-6_20'


 

This table displays all metadata directly associated to this object as RDF triples.

171 TRIPLES      23 PREDICATES      125 URIs      118 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-59259-852-6_20 schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author N270fc988d4b24d228f8d8a64d62ee8f7
4 schema:datePublished 2005
5 schema:datePublishedReg 2005-01-01
6 schema:description The pathological process that underlies idiopathic Parkinson’s disease (IPD) progresses relentlessly and requires years to reach its full extent, provided it is not terminated prematurely by death. The severity of the pathology increases gradually during the course of the disorder (1–8). As such, the lesions develop already, to a mild or moderate degree, even in the nervous system of persons whose clinical protocols fail to note the onset or presence of classical IPD-associated motor symptoms (9–17). Thus, the course of the disease process can be subdivided into presymptomatic and symptomatic phases (Fig. 1A). (3, 5) Like the tip of an iceberg, it is only the symptomatic, later phase of the larger degenerative process that presently can be detected clinically.Fig. 1. (A)Presymptomatic and symptomatic phases of idiopathic Parkinson’s disease (IPD). The presymptomatic phase of the disorder is characterized by the appearance of IPD-associated lesions in the brain of asymptomatic persons. Individuals first become symptomatic when the neuropathological threshold is exceeded (approximated by the white vertical line). Increasing density of the shading in areas underneath the diagonal indicates the growing severity of the pathology in vulnerable key regions indicated at the right-hand margin. Arabic numerals mark the stages of the neuropathological process. (B-D) Schematic diagrams showing the gradual ascent of the pathological process underlying IPD (white arrows). (E) Selective vulnerability and resistance of specific neuronal types to IPD. Projection cells that generate long and thin axons are among the nerve cell types most vulnerable to the pathology, whereas projection cells and local circuit neurons with short axon resist the lesions. Heavy axonal myelination offers the following advantages: high speed of conduction, low energy expenditure, greater stability of the parent neuron. Resistant against IPD-related pathology are long-axoned and sturdily myelinated projection neurons. In contrast, vulnerable neuronal types give off unmyelinated or poorly myelinated and thin axons. Reproduced from ref. 6 with permission from Steinkopff Verlag.
7 schema:editor Nd447d9d74ce14042993cbaef80c41cd4
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N2e154567e46a4a14b2a73b123ddb14f2
12 schema:keywords Arabic numerals
13 Body Pathology
14 Heavy axonal myelination
15 IPD-related pathology
16 Intracerebral Inclusion Body Pathology
17 Parkinson's disease
18 Ref. 6
19 Steinkopff Verlag
20 Verlag
21 advantages
22 appearance
23 appearance of IPD
24 area
25 ascent
26 asymptomatic persons
27 axonal myelination
28 axons
29 brain
30 cell types
31 cells
32 circuit neurons
33 classical idiopathic Parkinson's disease
34 clinical protocols
35 conduction
36 contrast
37 course
38 death
39 degenerative process
40 degree
41 density
42 diagram
43 disease
44 disease process
45 disorders
46 energy expenditure
47 expenditure
48 extent
49 full extent
50 gradual ascent
51 greater stability
52 high speed
53 icebergs
54 idiopathic Parkinson's disease
55 inclusion body pathology
56 individuals
57 key regions
58 larger degenerative process
59 late phase
60 lesions
61 local circuit neurons
62 lower energy expenditure
63 margin
64 moderate degree
65 motor symptoms
66 myelination
67 nerve cell types
68 nervous system
69 neuronal types
70 neurons
71 neuropathological processes
72 neuropathological threshold
73 numerals
74 onset
75 parent neurons
76 pathological processes
77 pathology
78 permission
79 persons
80 phase
81 presence
82 presymptomatic phase
83 process
84 projection cells
85 projection neurons
86 protocol
87 region
88 resistance
89 right-hand margin
90 schematic diagram
91 selective vulnerability
92 severity
93 shading
94 short axons
95 specific neuronal types
96 speed
97 stability
98 stage
99 symptomatic phase
100 symptomatic stage
101 symptoms
102 system
103 thin axons
104 threshold
105 tip
106 types
107 vulnerability
108 vulnerable key regions
109 vulnerable neuronal types
110 years
111 schema:name Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson’s Disease
112 schema:pagination 475-502
113 schema:productId N0120fce9e68248b4a1333ef6f7ee94b9
114 N319f2a214ea84df0975326e076d8db38
115 schema:publisher N1be286c08cf74c06a5266f00d60ed8ca
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053640909
117 https://doi.org/10.1007/978-1-59259-852-6_20
118 schema:sdDatePublished 2021-11-01T18:58
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher N9797bd4d58ab418bb9f17a277e1977b3
121 schema:url https://doi.org/10.1007/978-1-59259-852-6_20
122 sgo:license sg:explorer/license/
123 sgo:sdDataset chapters
124 rdf:type schema:Chapter
125 N0120fce9e68248b4a1333ef6f7ee94b9 schema:name dimensions_id
126 schema:value pub.1053640909
127 rdf:type schema:PropertyValue
128 N0414d32b6b43409dad0bbf53d8c611c0 schema:familyName Reith
129 schema:givenName Maarten E. A.
130 rdf:type schema:Person
131 N1be286c08cf74c06a5266f00d60ed8ca schema:name Springer Nature
132 rdf:type schema:Organisation
133 N270fc988d4b24d228f8d8a64d62ee8f7 rdf:first sg:person.01053255500.71
134 rdf:rest N51658440e6d54ad59362cf2590b53d2b
135 N2e154567e46a4a14b2a73b123ddb14f2 schema:isbn 978-1-58829-325-1
136 978-1-59259-852-6
137 schema:name Dopamine and Glutamate in Psychiatric Disorders
138 rdf:type schema:Book
139 N319f2a214ea84df0975326e076d8db38 schema:name doi
140 schema:value 10.1007/978-1-59259-852-6_20
141 rdf:type schema:PropertyValue
142 N51658440e6d54ad59362cf2590b53d2b rdf:first sg:person.01340323332.00
143 rdf:rest rdf:nil
144 N7e32d636e7164cc19ff19b2c5ee185f1 rdf:first N0414d32b6b43409dad0bbf53d8c611c0
145 rdf:rest rdf:nil
146 N88437c4eceef419da76895735440ad93 schema:familyName Schmidt
147 schema:givenName Werner J.
148 rdf:type schema:Person
149 N9797bd4d58ab418bb9f17a277e1977b3 schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 Nd447d9d74ce14042993cbaef80c41cd4 rdf:first N88437c4eceef419da76895735440ad93
152 rdf:rest N7e32d636e7164cc19ff19b2c5ee185f1
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
157 schema:name Neurosciences
158 rdf:type schema:DefinedTerm
159 sg:person.01053255500.71 schema:affiliation grid-institutes:grid.7839.5
160 schema:familyName Braak
161 schema:givenName Heiko
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053255500.71
163 rdf:type schema:Person
164 sg:person.01340323332.00 schema:affiliation grid-institutes:grid.7839.5
165 schema:familyName Del Tredici
166 schema:givenName Kelly
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340323332.00
168 rdf:type schema:Person
169 grid-institutes:grid.7839.5 schema:alternateName Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany
170 schema:name Institute for Clinical Neuroanatomy, J. W. Goethe University, Frankfurt/Main, Germany
171 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...